During the past decade, Krajska Nemocnice Liberec a.s. conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 11 clinical trials were completed, i.e. on average, 42.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krajska Nemocnice Liberec a.s." #1 sponsor was "Bayer" with 5 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Henogen" with 3 trials sponsored and "AO Clinical Investigation and Publishing Documentation" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krajska Nemocnice Liberec a.s." #1 collaborator was "Charles University, Czech Republic" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "University Hospital Pilsen" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator and "AG Mednet Inc." with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Krajska Nemocnice Liberec a.s." are "Hepatitis B" (3 trials), "Atrial Fibrillation" (2 trials), "Cardiogenic Shock" (2 trials), "Heart Failure" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Krajska Nemocnice Liberec a.s." in a lesser frequency.

Most popular intervention types in "Krajska Nemocnice Liberec a.s." are "Drug" (32 trials), "Other" (8 trials), "Biological" (7 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Gemcitabine" (2 trials), "Niraparib" (2 trials), "Paclitaxel" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

The vast majority of trials in "Krajska Nemocnice Liberec a.s." are 43 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Krajska Nemocnice Liberec a.s.". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Krajska Nemocnice Liberec a.s., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Krajska Nemocnice Liberec a.s., 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".